43rd Symposium on Hormones and Cell Regulation
European Society of Endocrinology (ESE)


The brain – gut – microbiome network in metabolic regulation and dysregulation




Wednesday 10th October


15:00 – 16.00  Bus arrives and cold lunch


16:00 – 16:10  Welcome


16:10 – 18:10  Cross-talk between the gut and the brain in metabolic regulation (Chair: Stephane Schurmans)


16:10 – 16:50  Jarrad M.Scarlett, University of Washington. Seattle, USA

                        Role of the brain in the pathogenesis of obesity, insulin resistance and type 2 diabetes.


16:50 – 17:30  Shiho Fujisaka, University of Toyama, Japan

                        Interaction between the gut microbiota and metabolites in insulin resistance and metabolic syndrome.


17:30 – 18:10  Amandine Everard, UCL, Brussels, Belgium

                       Cross-talk between the gut microbiota and the brain during metabolic disorders.


18:10 – 18:50  Vassilis Pachnis, Francis Crick Institute, London, UK

                       Control of the gastrointestinal tract by the enteric neuronal system.


19:00 – 20:30  Dinner


20:30 – 21:30  The first Jacques E. Dumont keynote lecture

                      (Chair: Nathalie Delzenne)

                       Jens Juul Holst, University of Copenhagen, Denmark

                       The endocrine function of the gut.



21:30           Posters, wine/beer



Thursday 11th October


8:30 – 13:00   The gut microbiota: a complex ecosystem and its interaction with host cells (Chair: Stefan Offermanns)


8:30 – 9:10  Colin Hill, University College Cork, Ireland

          Overview of gut microorganisms and their implication in shaping host metabolism.

9:10 – 9:50  Oluf Pedersen, University of Copenhagen, Denmark  

         The intestinal microbiome and human metabolism.


9:50 – 10:30  Eran Elinav, Weizmann Institute, Jerusalem, Israel

                       Environmental, nutritional and endogenous modulation of the microbiota.


10:30 – 11:00  Coffee break


11:00 – 11:40  Siegfried Ussar, Helmholtz Diabetes Center, München, Germany

                       Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome.


11:40 – 12:20  Peter Holzer, University of Graz, Austria

                       Gut – brain – microbiome interactions in obesity and depression.


12:20 – 13:00  Two short talks from abstracts.


13:00 – 14:30   Lunch


14:30 – 16:30   Walk around Mt Ste Odile


16:30 – 19:10   New mediators/targets in gut function

    (Chair: Veit Flockerzi)


16:30 – 17:10  Bart Staels, Institut Pasteur, Lille, France

                       Bile acids as metabolic regulators of endocrine function and energy metabolism.


17:10 – 17:50  Ellen Blaak, Maastricht University, The Netherlands

                       Short chain fatty acids as mediators of host energy metabolism.


17:50 – 18:30  Gilles Mithieux, INSERM, Lyon, France

                       Regulation of intestinal gluconeogenesis: which consequences for neuroendocrine function and energy metabolism?


18:30 – 20:00  Dinner


20:00 – 21:00  Keynote lecture (sponsored by LNC Therapeutics)

                          (Chair: Pierre De Meyts)   

                       Karine Clément, Pitié-Salpêtrière, Paris, France

                       Organ cross-talk in the pathophysiology of obesity


21:00  Posters, wine/beer




Friday 12th October


8:30 - 12:30  The gut microbiome in metabolic regulation and dysregulation across lifespan (Chair: Adriana Maggi)


8:30 – 9:10  Herbert Tilg, Medical University, Innsbrück, Austria

                       Gut dysfunction and non-alcoholic fatty liver


9:10 – 9:50  Louise Olofsson, Salghrenska Academy, University of Göteborg, Sweden

                       Mechanistic studies of the impact of the gut microbiome on obesity and type 2 diabetes.


9:50 – 10:30  Remy Burcelin, INSERM, Paul Sabatier University, Toulouse, France.

                      Gut barrier and bacterial translocation in metabolic diseases.


10:30 – 11:00  Coffee break


11:00 – 11:40  Joël Doré, Metagenopolis, INRA, Paris, France

                       Do metagenomics approaches in cohorts support a key role for gut microbiome in metabolic diseases?


11:40 – 12:20  Two short talks selected from abstracts


12:30 – 14:00   Lunch


14:00 - 14:40  Patrizia Brigidi, University of Bologna, Italy

                       The gut microbiota of centenarians: signatures of longevity in the gut microbiota profiles.


14:40 – 18:00  The gut microbiome and CNS dysfunction

                      (Chair: Jean-Philippe Pin)


14:40 – 15:20  Tristan Bolmont, Stemedica International, Lausanne, Switzerland

                       Gut microbiota alterations in Alzheimer’s disease: from preclinics to clinical studies.


15:20 – 15:50  Coffee break


15:50 – 16:30  Sylvie Claeysen, INSERM U661, University of Montpellier, France

                       Microbiota influence on Alzheimer’s development


16:30 – 17:10  Helen Vuong, UCLA, Los Angeles, USA

                       Maternal microbiome and neurodevelopment.


17:10 – 17:40  John Cryan, University College Cork, Ireland

                       Gut-brain axis revisited: which role for the gut microbiota in mood and depression?


17:40 – 18:00 Short talk selected from abstracts.


18:00 – 19:00 Keynote lecture (Chair: Maria Sibilia)

                       Emrah Altindis, Boston College, Boston, USA

                       Viral insulin like peptides activate insulin and IGF-I receptor signalling: a paradigm shift in host microbe interactions.


19:00 – 21:00 Wine tasting and gala dinner


21:00  Posters, wine/beer




Saturday 13th October


9:00 – 11:40  Therapeutic perspectives (Chair: David Carling)


9:00 – 9:40   Filipe Cabreiro, UCL, London, UK

                       Effects of drug-nutrient-microbe interactions on host physiology and lifespan.


9:40 – 10:20  Nathalie Delzenne, UCL, Brussels, Belgium

                       Feeding the gut microbiota with prebiotic dietary fibers: therapeutic interest in metabolic disorders.



10:20 – 10:50  Coffee break


10:50 – 11:30   Max Nieuwdorp, Akademisch Medisch Centrum, University of Amsterdam, The Netherlands

                       Gut microbial transfer from healthy to diseased (T2D) individuals.


11:30 – 12:30   Keynote lecture (Chair: Jacques E. Dumont)


Hubert Vidal, CarMeN laboratory, INSERM U1060, University of  Lyon, France.

                       Development of new probiotics for the treatment of diabetes/insulin resistance.


12:30 Lunch


13:30 Bus transfer














with the support of ...                                                Avec le soutien de ...